Skip to main content
Clinical Trials/ACTRN12610000615088
ACTRN12610000615088CompletedPhase 2

The effects in critically ill patients of erythromycin when compared to placebo on small intestinal transit and nutrient absorption

Adam Deane0 sites15 target enrollmentStarted: July 28, 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Adam Deane
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 90 Years (—)
Sex
All

Inclusion Criteria

  • •Sedated and mechanically ventilated, critically ill patients Aged greater than 17 years, suitable for or receiving post-pyloric nutrition and likely to stay ventilated for at least 48 hours.

Exclusion Criteria

  • •Pregnancy, Any contraindication to enteral feeding, Previous surgery on the oesophagus, stomach or duodenum, Any gastrointestinal surgery during their current hospital admission, Contraindication to moderate level of sedation or the use of an opiate for sedation and/or analgesia, Patients receiving erythromycin at an antimicrobial dose, Liver Dysfunction (defined as alanine a minotransferase (ALT) > 3 times the upper limit of normal)

Investigators

Sponsor
Adam Deane

Similar Trials